These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15649105)

  • 1. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.
    Núñez M; Soriano V
    Drug Saf; 2005; 28(1):53-66. PubMed ID: 15649105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.
    Núñez M
    J Hepatol; 2006; 44(1 Suppl):S132-9. PubMed ID: 16364487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decade.
    Sauleda S; Martorell M; Esteban JI; Tural C; Ruiz I; Puig L; Esteban R; Guardia J; Vargas V
    Haemophilia; 2006 May; 12(3):228-36. PubMed ID: 16643206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy].
    Lana R; Núñez M; Mendoza JL; Soriano V
    Med Clin (Barc); 2001 Nov; 117(16):607-10. PubMed ID: 11714465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver involvement in human immunodeficiency virus infection.
    Puri P; Kumar S
    Indian J Gastroenterol; 2016 Jul; 35(4):260-73. PubMed ID: 27256434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
    Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
    Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
    Torti C; Lapadula G; Casari S; Puoti M; Nelson M; Quiros-Roldan E; Bella D; Pastore G; Ladisa N; Minoli L; Sotgiu G; Mazzotta F; Lo Caputo S; Di Perri G; Filice G; Tinelli C; Carosi G;
    BMC Infect Dis; 2005 Jul; 5():58. PubMed ID: 16018804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.
    Kalyesubula R; Kagimu M; Opio KC; Kiguba R; Semitala CF; Schlech WF; Katabira ET
    Afr Health Sci; 2011 Mar; 11(1):16-23. PubMed ID: 21572852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
    Sulkowski MS; Thomas DL; Mehta SH; Chaisson RE; Moore RD
    Hepatology; 2002 Jan; 35(1):182-9. PubMed ID: 11786975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection.
    Aceti A; Pasquazzi C; Zechini B; De Bac C;
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):41-8. PubMed ID: 11782588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.
    Darge T; Babusha A; Chilo D; Dukessa A; Teferi S
    Sci Rep; 2024 Apr; 14(1):8473. PubMed ID: 38605149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.
    Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-related liver disease: infections versus drugs.
    Sidiq H; Ankoma-Sey V
    Gastroenterol Clin North Am; 2006 Jun; 35(2):487-505. PubMed ID: 16880076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
    Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
    BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.
    Moodie EE; Pant Pai N; Klein MB
    PLoS One; 2009; 4(2):e4517. PubMed ID: 19223976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
    Jones M; Núñez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
    den Brinker M; Wit FW; Wertheim-van Dillen PM; Jurriaans S; Weel J; van Leeuwen R; Pakker NG; Reiss P; Danner SA; Weverling GJ; Lange JM
    AIDS; 2000 Dec; 14(18):2895-902. PubMed ID: 11153671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
    Pol S; Lebray P; Vallet-Pichard A
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S65-72. PubMed ID: 14986277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.